| Guidelines on nicotine dose selection for in vivo research SG Matta, DJ Balfour, NL Benowitz, RT Boyd, JJ Buccafusco, ... Psychopharmacology 190, 269-319, 2007 | 897 | 2007 |
| Tumor necrosis factor-α is a potent ACTH secretagogue: comparison to interleukin-1β BM SHARP, SG MATTA, PK PETERSON, R NEWTON, C CHAO, ... Endocrinology 124 (6), 3131-3133, 1989 | 258 | 1989 |
| Regulation of the messenger ribonucleic acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites of the rat HS BEYER, SG MATTA, BM SHARP Endocrinology 123 (4), 2117-2123, 1988 | 184 | 1988 |
| Response of the hypothalamo-pituitary-adrenal axis to nicotine SG Matta, Y Fu, JD Valentine, BM Sharp Psychoneuroendocrinology 23 (2), 103-113, 1998 | 174 | 1998 |
| Self-administration in rats allowed unlimited access to nicotine JD Valentine, JS Hokanson, SG Matta, BM Sharp Psychopharmacology 133 (3), 300-304, 1997 | 163 | 1997 |
| Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role ofN-methyl-d-aspartate receptors in the ventral tegmental area Y Fu, SG Matta, W Gao, VG Brower, BM Sharp Journal of Pharmacology and Experimental Therapeutics 294 (2), 458-465, 2000 | 161 | 2000 |
| Nicotine up-regulates expression of orexin and its receptors in rat brain JK Kane, SL Parker, SG Matta, Y Fu, BM Sharp, MD Li Endocrinology 141 (10), 3623-3629, 2000 | 154 | 2000 |
| Acquisition of nicotine self-administration in adolescent rats given prolonged access to the drug H Chen, SG Matta, BM Sharp Neuropsychopharmacology 32 (3), 700-709, 2007 | 151 | 2007 |
| Nicotine administration enhances NPY expression in the rat hypothalamus MD Li, JK Kane, SL Parker, K McAllen, SG Matta, BM Sharp Brain Research 867 (1-2), 157-164, 2000 | 141 | 2000 |
| Nicotine stimulates the expression of cFos protein in the parvocellular paraventricular nucleus and brainstem catecholaminergic regions SG Matta, CA Foster, BM Sharp Endocrinology 132 (5), 2149-2156, 1993 | 118 | 1993 |
| An ultra-short dopamine pathway regulates basal ganglia output FW Zhou, Y Jin, SG Matta, M Xu, FM Zhou Journal of Neuroscience 29 (33), 10424-10435, 2009 | 112 | 2009 |
| Nicotine elevates rat plasma ACTH by a central mechanism. SG Matta, HS Beyer, KM McALLEN, BM Sharp Journal of Pharmacology and Experimental Therapeutics 243 (1), 217-226, 1987 | 109 | 1987 |
| Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors Y Fu, SG Matta, TJ James, BM Sharp Journal of pharmacology and experimental therapeutics 284 (3), 1188-1196, 1998 | 108 | 1998 |
| Rat strain differences in nicotine self-administration using an unlimited access paradigm VG Brower, Y Fu, SG Matta, BM Sharp Brain research 930 (1-2), 12-20, 2002 | 103 | 2002 |
| The adrenocorticotropin response to interleukin-1β instilled into the rat median eminence depends on the local release of catecholamines SG MATTA, J SINGH, R NEWTON, BM SHARP Endocrinology 127 (5), 2175-2182, 1990 | 101 | 1990 |
| Constitutively active TRPC3 channels regulate basal ganglia output neurons FW Zhou, SG Matta, FM Zhou Journal of Neuroscience 28 (2), 473-482, 2008 | 99 | 2008 |
| A central mechanism is involved in the secretion of ACTH in response to IL-6 in rats: comparison to and interaction with IL-1β SG Matta, J Weatherbee, BM Sharp Neuroendocrinology 56 (4), 516-525, 1992 | 97 | 1992 |
| Gestational nicotine exposure reduces nicotinic cholinergic receptor (nAChR) expression in dopaminergic brain regions of adolescent rats H Chen, SL Parker, SG Matta, BM Sharp European Journal of Neuroscience 22 (2), 380-388, 2005 | 90 | 2005 |
| Neuritogenic and metabolic effects of individual gangliosides and their interaction with nerve growth factor in cultures of neuroblastoma and pheochromocytoma SG Matta, G Yorke, FJ Roisen Developmental Brain Research 27 (1), 243-252, 1986 | 79 | 1986 |
| Gestational nicotine exposure attenuates nicotine-stimulated dopamine release in the nucleus accumbens shell of adolescent Lewis rats VB Kane, Y Fu, SG Matta, BM Sharp Journal of Pharmacology and Experimental Therapeutics 308 (2), 521-528, 2004 | 77 | 2004 |
